Immunization News and Research

RSS

Immune-boosting vaccine helps body fight cancer

Cancer Research UK-funded scientists have discovered that linking a molecule which initiates antibody production,to a 'saboteur' molecule, triggers the immune system to selectively destroy faulty cells. These findings published in Blood, could potentially be used to selectively destroy tumour cells while ignoring healthy cells.

23 Apr 2009

Stakeholders participate in regional White House forum on health care reform

At Monday's White House forum on health care reform held in Los Angeles, the discussion concerning how to fix our broken health care system and cover the 47 million Americans (6.8 million Californians) who are uninsured underscored the need for action now.

9 Apr 2009

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

30 Mar 2009

Breakthrough improves effectiveness of tuberculosis vaccine

A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University of Texas Health Science Center at Houston in Nature Medicine 's Advance Online Publication March 1.

8 Mar 2009

Antibody key to treating variant CJD

Scientists at the University of Liverpool have determined the atomic structure of the 'binding' between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD.

4 Mar 2009

Tuberculosis breakthrough could lead to stronger vaccine

3 Mar 2009

Universal vaccination associated with decreased Canadian cases of most deadly strain of meningitis

Universal childhood vaccination against meningococcal C appears to reduce Canadian incidence of the most deadly strain of bacterial meningitis, reports new research published in the March issue of The Pediatric Infectious Disease Journal.

2 Mar 2009

Instant immunity through chemically programmable vaccination and covalent self-assembly

The experiments, thus far performed only in mice, appear to overcome a major drawback of vaccinations - the lag time of days, or even weeks, that it normally takes for immunity to build against a pathogen.

2 Mar 2009

Wyeth's Prevenar vaccine for pneumococcal disease registered in Russia

Wyeth announced today that its 7-valent pneumococcal conjugate vaccine, Prevenar (Pneumococcal saccharide conjugated vaccine, Adsorbed), has been registered by the Russian Ministry of Health and Social Development (Roszdravnadzor) and is expected to be commercially available later this year.

2 Mar 2009

Experimental animal vaccine may protect humans from Ebola

Protection against Ebola, one of the world's deadliest viruses, can be achieved by a vaccine produced in insect cells, raising prospects for developing an effective vaccine for humans, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

26 Feb 2009

Putting a face on influenza

Influenza results in billions of dollars in lost wages every year, and recent studies found that an estimated 75 million missed workdays a year, and about 200 million days of restricted activity, are due to this vaccine-preventable disease.

24 Feb 2009

One-quarter of California adolescent girls has had HPV vaccine

Less than two years after the HPV vaccine was approved as a routine vaccination for girls aged 11 and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, which is strongly linked to cervical cancer.

18 Feb 2009

5-in-1 combo vaccine increases on-time immunization in children

A "5-in-1" combination vaccine increases the percentage of children receiving all recommended vaccinations at the scheduled time, reports a study in the February issue of The Pediatric Infectious Disease Journal.

11 Feb 2009

BioGenes as new designated partner in EU funded dementia project

BioGenes GmbH, a specialist in sophisticated antibody development, has been chosen as a new partner of cNEUPRO. cNEUPRO is a EU funded research project to analyse neurodegenerative diseases and discover novel biomarkers, and so improve early and differential diagnosis of Alzheimer's dementia.

2 Feb 2009

All countries should offer universal infant immunization for hepatitis B

All countries should offer universal infant immunization for hepatitis B, write Dr. Christopher Mackie from McMaster University and coauthors in a public health analysis in CMAJ.

19 Jan 2009

Pneumococcal polysaccharide vaccines do not appear to protect against pneumonia

Commonly used pneumococcal polysaccharide vaccines do not appear to be effective for preventing pneumonia, found a study by a team of researchers from Switzerland and the United Kingdom.

5 Jan 2009

Adults with asthma at increased risk of serious pneumococcal disease

Mayo Clinic research shows adults with asthma are at increased risk of serious pneumococcal disease caused by Streptococcus pneumoniae, the most common bacteria causing middle ear infections and community acquired pneumonia.

22 Dec 2008

GlaxoSmithKline ready to supply Biota's Relenza to meet CDC recommendations

GlaxoSmithKline (GSK) is prepared to respond to public health needs for Relenza (zanamivir) Inhalation Powder this flu season following a Health Alert Advisory issued by the Centers for Disease Control and Prevention (CDC).

21 Dec 2008

Policymakers, the media and the public should use 20 specific health indicators

Policymakers, the media, and the public should focus on 20 specific health indicators as "yardsticks" to measure the overall health and well-being of Americans, says a new report from the Institute of Medicine.

17 Dec 2008

NACCHO to donate up to one million doses of FluMist

The National Association of County and City Health Officials (NACCHO) has announced a donation of up to one million doses of FluMist (Influenza Virus Vaccine Live, Intranasal) by MedImmune in a partnership aimed at increasing influenza awareness and vaccinations in underserved communities and populations.

14 Dec 2008